Viewing Study NCT01894321



Ignite Creation Date: 2024-05-06 @ 1:46 AM
Last Modification Date: 2024-10-26 @ 11:09 AM
Study NCT ID: NCT01894321
Status: COMPLETED
Last Update Posted: 2013-07-10
First Post: 2013-06-29

Brief Title: The Clinical Outcomes of the Percutaneous Cholecystostomy Supportive Care Versus Cholecystectomy
Sponsor: Cheju Halla General Hospital
Organization: Cheju Halla General Hospital

Study Overview

Official Title: The Percutaneous Cholecystostomy is Appropriate as the Ultimate Treatment of Acute Cholecystitis in Critically Ill Patients a Cross-sectional Study at Single Center
Status: COMPLETED
Status Verified Date: 2013-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Percutaneous cholecystostomy PC is an effective treatment for cholecystitis in surgical high risk patients However there has been no definite agreement of the additional cholecystectomy in these patients The investigators surveyed the clinical outcomes of the PC in surgical high risk patients And the investigators tried to prove the PC can be appropriate and ultimate treatment for acute cholecystitis patients with critical illness through this study
Detailed Description: Between 2007 and 2012 all patients admitted for acute cholecystitis and then underwent ultrasonography guided percutaneous cholecystostomy in Cheju Halla General Hospital were consecutively enrolled

Among 82 patients 35 were performed laparoscopic cholecystectomy after recovery Cholecystectomy group and 47 treated by best supportive care without additional surgery BSC group

The investigators analyzed their surgical risks and clinical outcomes of both patients retrospectively

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None